Brief: Arecor Therapeutics Reports Positive Headline Results For AT278 Clinical Trial
20/05/2024 07:15
May 20 (Reuters) - Arecor Therapeutics PLC AREC.L :
* ARECOR THERAPEUTICS - POSITIVE HEADLINE RESULTS FOR AT278
CLINICAL TRIAL
* ARECOR THERAPEUTICS - AT278 MET ALL PRIMARY AND SECONDARY
ENDPOINTS IN A PHASE I CLINICAL TRIAL IN TYPE 2 DIABETICS WITH A
HIGH BODY MASS INDEX
Source text for Eikon: ID:nRST0062Pa
Further company coverage: AREC.L
((Reuters.Briefs@thomsonreuters.com;))